A dried blood spot protocol for high throughput analysis of SARS-CoV-2 serology based on the Roche Elecsys anti-N assay

BACKGROUND: Since 2020 SARS-CoV-2 spreads pandemically, infecting more than 119 million people, causing >2·6 million fatalities. Symptoms of SARS-CoV-2 infection vary greatly, ranging from asymptomatic to fatal. Different populations react differently to the disease, making it very hard to track...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyerl, Jessica, Rubio-Acero, Raquel, Castelletti, Noemi, Paunovic, Ivana, Kroidl, Inge, Khan, Zohaib N., Bakuli, Abhishek, Tautz, Andreas, Oft, Judith, Hoelscher, Michael, Wieser, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320407/
https://www.ncbi.nlm.nih.gov/pubmed/34333234
http://dx.doi.org/10.1016/j.ebiom.2021.103502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320407/
https://www.ncbi.nlm.nih.gov/pubmed/34333234
http://dx.doi.org/10.1016/j.ebiom.2021.103502

Ejemplares similares